Dr Shahin Tabatabaei, MD - Medicare Urology in Boston, MA

Dr Shahin Tabatabaei, MD is a medicare enrolled "Urology" physician in Boston, Massachusetts. His current practice location is 15 Parkman St, Dept Of Urology Mgh, Boston, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 726-3010.

Dr Shahin Tabatabaei is licensed to practice in Massachusetts (license number 209109) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1760473292.

Contact Information

Dr Shahin Tabatabaei, MD
15 Parkman St, Dept Of Urology Mgh,
Boston, MA 02114-3117
(617) 726-3010
(617) 726-6131



Physician's Profile

Full NameDr Shahin Tabatabaei
GenderMale
SpecialityUrology
Location15 Parkman St, Boston, Massachusetts
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1760473292
  • Provider Enumeration Date: 11/03/2005
  • Last Update Date: 11/26/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 1456439850
  • Enrollment ID: I20080425000386

Medical Identifiers

Medical identifiers for Dr Shahin Tabatabaei such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1760473292NPI-NPPES
0188760MedicaidMA
J25678OtherMABCBS MA
209109OtherMATUFTS HEALTH PLAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 209109 (Massachusetts)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Shahin Tabatabaei allows following entities to bill medicare on his behalf.
Entity NameMassachusetts General Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801874573
PECOS PAC ID: 2466365820
Enrollment ID: O20031111000434

News Archive

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

Colorectal carcinoma is one of the most common cancers in the world. Approximately one in four of these patients have metastases at diagnosis, liver being the most common site involved. Although historically it was considered that liver metastases meant a very poor prognosis, today, due to improved systemic therapy, many patients will be candidates for local hepatic treatments such as surgery or less aggressive radiofrequency ablation.

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

When a fall, car crash, bullet, or knife crushes or cuts a spinal cord, the injury does not stop there. Rather, tissues continue to discharge toxic chemicals for hours, even days and weeks. These chemicals kill and disable nerve cells some distance away from the core injury, compounding the damage and making rehabilitation more difficult or impossible.

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that two first-in-class agents — Merck's telcagepant and CoLucid's lasmiditan — will earn combined sales of approximately $1.3 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

Scientists receive honorary doctorate for research on Alzheimer's disease

On Monday 4 February, Dennis J. Selkoe and five other "brain teasers" will receive an honorary doctorate from the KU Leuven. The promoters for this honorary doctorate - VIB-KU Leuven professors Bart De Strooper and Wim Robberecht - will honor Dennis J. Selkoe for his scientific insights, but also for his relentless search for new medicines to treat Alzheimer's Disease and other conditions that cause severe damage in the brain.

IVCC receives $50 million to develop new insecticides

The Innovative Vector Control Consortium has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.

Read more Medical News

› Verified 9 days ago

Entity NameThe General Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023049236
PECOS PAC ID: 6507803806
Enrollment ID: O20080313000351

News Archive

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

Colorectal carcinoma is one of the most common cancers in the world. Approximately one in four of these patients have metastases at diagnosis, liver being the most common site involved. Although historically it was considered that liver metastases meant a very poor prognosis, today, due to improved systemic therapy, many patients will be candidates for local hepatic treatments such as surgery or less aggressive radiofrequency ablation.

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

When a fall, car crash, bullet, or knife crushes or cuts a spinal cord, the injury does not stop there. Rather, tissues continue to discharge toxic chemicals for hours, even days and weeks. These chemicals kill and disable nerve cells some distance away from the core injury, compounding the damage and making rehabilitation more difficult or impossible.

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that two first-in-class agents — Merck's telcagepant and CoLucid's lasmiditan — will earn combined sales of approximately $1.3 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

Scientists receive honorary doctorate for research on Alzheimer's disease

On Monday 4 February, Dennis J. Selkoe and five other "brain teasers" will receive an honorary doctorate from the KU Leuven. The promoters for this honorary doctorate - VIB-KU Leuven professors Bart De Strooper and Wim Robberecht - will honor Dennis J. Selkoe for his scientific insights, but also for his relentless search for new medicines to treat Alzheimer's Disease and other conditions that cause severe damage in the brain.

IVCC receives $50 million to develop new insecticides

The Innovative Vector Control Consortium has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Shahin Tabatabaei is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Shahin Tabatabaei, MD
Po Box 9142, Mass General Physician Organization,
Charlestown, MA 02129-9142

Ph: (617) 726-3574
Dr Shahin Tabatabaei, MD
15 Parkman St, Dept Of Urology Mgh,
Boston, MA 02114-3117

Ph: (617) 726-3010

News Archive

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

Colorectal carcinoma is one of the most common cancers in the world. Approximately one in four of these patients have metastases at diagnosis, liver being the most common site involved. Although historically it was considered that liver metastases meant a very poor prognosis, today, due to improved systemic therapy, many patients will be candidates for local hepatic treatments such as surgery or less aggressive radiofrequency ablation.

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

When a fall, car crash, bullet, or knife crushes or cuts a spinal cord, the injury does not stop there. Rather, tissues continue to discharge toxic chemicals for hours, even days and weeks. These chemicals kill and disable nerve cells some distance away from the core injury, compounding the damage and making rehabilitation more difficult or impossible.

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that two first-in-class agents — Merck's telcagepant and CoLucid's lasmiditan — will earn combined sales of approximately $1.3 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

Scientists receive honorary doctorate for research on Alzheimer's disease

On Monday 4 February, Dennis J. Selkoe and five other "brain teasers" will receive an honorary doctorate from the KU Leuven. The promoters for this honorary doctorate - VIB-KU Leuven professors Bart De Strooper and Wim Robberecht - will honor Dennis J. Selkoe for his scientific insights, but also for his relentless search for new medicines to treat Alzheimer's Disease and other conditions that cause severe damage in the brain.

IVCC receives $50 million to develop new insecticides

The Innovative Vector Control Consortium has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.

Read more News

› Verified 9 days ago


Urology Doctors in Boston, MA

Brian Howard Eisner, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114
Phone: 617-726-3512    
Catherine Gu, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: Bwh 75 Francis St, Boston, MA 02115
Phone: 617-732-5500    
Dr. Dianne E Sacco, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fruit St, Dept Of Urology, Boston, MA 02114
Phone: 617-726-3760    Fax: 617-726-6131
Peter Lang Steinberg, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215
Phone: 617-667-3739    
Richard N Yu, M.D, PH.D.
Urology
Medicare: May Accept Medicare Assignments
Practice Location: 300 Longwood Ave, Department Of Urology, Hu-390, Boston, MA 02115
Phone: 617-355-7796    
Dr. Quoc-dien Trinh, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 45 Francis St, Division Of Urology, Boston, MA 02115
Phone: 617-525-7350    
Dr. Melise A Keays, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 300 Longwood Ave, Boston, MA 02115
Phone: 617-355-6000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.